The Medical Linear Accelerator Market is expected to register a CAGR of 8.2% during the forecast period. High prevalence of cancer and technological advancements in product is expected to drive the medical linear accelerator market growth. According to Cancer Research UK, approximately 17 million people were diagnosed with cancer globally in 2018. Moreover, most cancers are diagnosed at the last stage of it. Hence, as the incidence of cancer is increasing the demand for treatment will also increase and thereby expected to boost the medical linear accelerator market growth.
Key Market Trends
Stereotactic Radiosurgery /Stereotactic Body Radiotherapy Segment is Expected to Hold a Major Market Share in the Medical Linear Accelerator Market
- Stereotactic radiosurgery and steretactic body radiotherapy is a type of external radiotherapy that uses high energy photons to destroy cancerous cells while sparing healthy cells. Linear accelerator based stereotactic radiosurgery is rapidly increasing for the treatment in cancer and other neurological disorder such as trigeminal neurolagia.
- One of the study published in 2017, by Journal of Applied Clinical Medical Physics revealed that linear accelerator based stereotactic surgery was found to be very effective in case of trigeminal neuralgia. Furthermore, with the wide accepentance of non-invasive surgery, the market is expected to increase.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global medical linear accelerator market due to growing burden of diseases such as cancer and trigeminal neuralgia. According to Trigeminal Neuralgia Association of Canada, almost each year 5 per 100,000 people are diagnosed with trigeminal neuralgia in Canada. Furthermore, according to National Organization for Rare Disorders, trigeminal neuralgia is affecting between 10,000 to 15,000 people each year in the United States. One of its treatment include stereotactic surgery by using modified linear accelerator. Thus, these factors are expected to propel the medical linear accelerator market growth in North America.
The Medical Linear Accelerator Market is consolidated and consists of several major players. Companies are collaborating to develop the linear accelerators. For instance, in 2018, Elekta AB received it USFDA approval for its Elekta Unity, MR-linac (linear accelerator). It is used for mainly treating cancer by personalized radiation therapy. Some of the major players in the market are Varian Medical Systems, Inc., Accuray Inc., Viewray Technologies Inc., Elekta AB, Siemens Healthcare and Shinva Medical Instrument Co. Ltd.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Growing Burden of Diseases
4.2.2 Advancement in Product
4.3 Market Restraints
4.3.1 Lack of Trained Professionals
4.3.2 Stringent Regulatory Framework
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Dedicated Linear Accelerator
5.1.2 Non-Dedicated Linear Accelerator
5.2 By Treatment Type
5.2.1 Intensity Modulated Radiation Therapy
5.2.2 Volumetric Modulated Arc Therapy
5.2.3 Image Guided Radiation Therapy
5.2.4 Stereotactic Radiosurgery/Stereotactic Body Radiotherapy
5.3.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
220.127.116.11 South Africa
18.104.22.168 Rest of Middle-East and Africa
5.3.5 South America
22.214.171.124 Rest of South America
6.1.1 Accuray Inc.
6.1.2 Elekta AB
6.1.3 Shinva Medical Instrument Co. Ltd.
6.1.4 Siemens Healthcare
6.1.5 Varian Medical Systems, Inc.
6.1.6 Viewray Technologies Inc.
A selection of companies mentioned in this report includes:
- Accuray Inc.
- Elekta AB
- Shinva Medical Instrument Co. Ltd.
- Siemens Healthcare
- Varian Medical Systems, Inc.
- Viewray Technologies Inc.